| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Achieving and maintaining quality in the laboratory
|
HERTZBERG, M. S.
|
|
2006
|
|
s3 |
p. 61-67
|
article
|
| 2 |
Arthroscopic synovectomy in haemophilia: indications, technique and results
|
VERMA, N.
|
|
2007
|
|
s3 |
p. 38-44
|
article
|
| 3 |
Cellular and genetic therapies for haemophilia
|
LILLICRAP, D.
|
|
2006
|
|
s3 |
p. 36-41
|
article
|
| 4 |
Congenital platelet disorders: overview of their mechanisms, diagnostic evaluation and treatment
|
HAYWARD, C. P. M.
|
|
2006
|
|
s3 |
p. 128-136
|
article
|
| 5 |
Current understanding of von Willebrand's disease in women – some answers, more questions
|
KOUIDES, P. A.
|
|
2006
|
|
s3 |
p. 143-151
|
article
|
| 6 |
Diagnosis of haemophilic synovitis
|
GODDARD, N. J.
|
|
2007
|
|
s3 |
p. 14-19
|
article
|
| 7 |
Ethical issues in haemophilia
|
DIMICHELE, D.
|
|
2006
|
|
s3 |
p. 30-35
|
article
|
| 8 |
Genetic diagnosis of haemophilia and other inherited bleeding disorders
|
PEYVANDI, F.
|
|
2006
|
|
s3 |
p. 82-89
|
article
|
| 9 |
Haemophilia and ageing
|
STREET, A.
|
|
2006
|
|
s3 |
p. 8-12
|
article
|
| 10 |
Haemophilic synovitis: basic concepts
|
RODRIGUEZ-MERCHAN, E. C.
|
|
2007
|
|
s3 |
p. 1-3
|
article
|
| 11 |
HIV and HCV coinfected haemophilia patients: what are the best options of orthopaedic treatment?
|
RODRIGUEZ-MERCHAN, E. C.
|
|
2006
|
|
s3 |
p. 90-101
|
article
|
| 12 |
Laboratory issues in bleeding disorders
|
LILLICRAP, D.
|
|
2006
|
|
s3 |
p. 68-75
|
article
|
| 13 |
New approaches for measuring coagulation
|
BARROWCLIFFE, T. W.
|
|
2006
|
|
s3 |
p. 76-81
|
article
|
| 14 |
Pathogenesis of haemophilic arthropathy
|
ROOSENDAAL, G.
|
|
2006
|
|
s3 |
p. 117-121
|
article
|
| 15 |
Pathogenesis of haemophilic synovitis: clinical aspects
|
HOOTS, W. K.
|
|
2007
|
|
s3 |
p. 4-9
|
article
|
| 16 |
Pathogenesis of haemophilic synovitis: experimental studies on blood-induced joint damage
|
VALENTINO, L. A.
|
|
2007
|
|
s3 |
p. 10-13
|
article
|
| 17 |
Physiotherapy following elective orthopaedic procedures
|
DE KLEIJN, P.
|
|
2006
|
|
s3 |
p. 108-112
|
article
|
| 18 |
Prevention and treatment of musculoskeletal disease in the haemophilia population: role of prophylaxis and synovectomy
|
VAN DEN BERG, H. M.
|
|
2006
|
|
s3 |
p. 159-168
|
article
|
| 19 |
Prevention of haemophilic synovitis: prophylaxis
|
LEE, C. A.
|
|
2007
|
|
s3 |
p. 20-25
|
article
|
| 20 |
Prophylaxis and treatment of chronic synovitis in haemophilia patients with inhibitors
|
RODRIGUEZ-MERCHAN, E. C.
|
|
2007
|
|
s3 |
p. 45-48
|
article
|
| 21 |
Quality of life assessment in clinical practice in haemophilia treatment
|
GRINGERI, A.
|
|
2006
|
|
s3 |
p. 22-29
|
article
|
| 22 |
Radioactive synoviorthesis for the treatment of haemophilic synovitis
|
RODRIGUEZ-MERCHAN, E. C.
|
|
2007
|
|
s3 |
p. 32-37
|
article
|
| 23 |
Rare bleeding disorders
|
PEYVANDI, F.
|
|
2006
|
|
s3 |
p. 137-142
|
article
|
| 24 |
Recent developments in clinimetric instruments
|
BEETON, K.
|
|
2006
|
|
s3 |
p. 102-107
|
article
|
| 25 |
Rehabilitation of synovitis in patients with haemophilia
|
SEUSER, A.
|
|
2007
|
|
s3 |
p. 26-31
|
article
|
| 26 |
Strategies towards a longer acting factor VIII
|
SAENKO, E. L.
|
|
2006
|
|
s3 |
p. 42-51
|
article
|
| 27 |
The natural evolution of haemophilia care: developing and sustaining comprehensive care globally
|
EVATT, B. L.
|
|
2006
|
|
s3 |
p. 13-21
|
article
|
| 28 |
The pharmacokinetics of coagulation factors
|
LEE, M.
|
|
2006
|
|
s3 |
p. 1-7
|
article
|
| 29 |
Tissue engineering in musculoskeletal problems related to haemophilia
|
CAVIGLIA, H.
|
|
2006
|
|
s3 |
p. 122-127
|
article
|
| 30 |
Total joint arthroplasty: the final solution for knee and hip when synovitis could not be controlled
|
RODRIGUEZ-MERCHAN, E. C.
|
|
2007
|
|
s3 |
p. 49-58
|
article
|
| 31 |
Total joint replacement in patients with inhibitors
|
SOLIMENO, L. P.
|
|
2006
|
|
s3 |
p. 113-116
|
article
|
| 32 |
Treatment for all: a vision for the future
|
SKINNER, M. W.
|
|
2006
|
|
s3 |
p. 169-173
|
article
|
| 33 |
Von Willebrand's disease: clinical management
|
FEDERICI, A. B.
|
|
2006
|
|
s3 |
p. 152-158
|
article
|
| 34 |
Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophilia
|
ASTERMARK, J.
|
|
2006
|
|
s3 |
p. 52-60
|
article
|
Journal description